Sort
21,453 grants matching “tuberculosis”
GUIDE: Genomic Uses in Infectious Diseases and Epidemics
$283,490Gail Geller · Johns Hopkins University · P20 · FY2013 · HG
Sequencing Core
$283,441Gregory Seumois · La Jolla Institute For Immunology · U19 · FY2019 · AI
UCSF-UCB TRAC ADMININSTRATIVE CORE
$283,339Payam Nahid · University Of California, San Francisco · P30 · FY2023 · AI
STRUCTURE/FUNCTION OF TWO DNA BINDING PROTEINS
$283,320University Of Washington · R01 · FY2002 · CA
Structural and functional studies of a PhoP-PhoR two-component system
$283,239Shuishu Wang · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2011 · GM
The roles of biologically relevant ncRNAs
$283,223Sarah M Fortune · Harvard School Of Public Health · U19 · FY2014 · AI
Bacterial Cell Wall Composition and the Influence of Antibiotics
$283,122Lynette S Cegelski · Stanford University · R01 · FY2017 · GM
A rapid, POC array MDR/XDR-TB genotyping.
$283,107Heather Koshinsky · Investigen, Inc. · R43 · FY2009 · AI
Structural Requirements for Sterol 14alpha-Demethylases
$283,107Michael R Waterman · Vanderbilt University · R01 · FY2006 · GM
Effect of Bacterial Tolerance on TLR Signal Transduction
$283,073University Of Maryland Baltimore · R01 · FY2005 · AI
OHet72: A potential new drug in the armamentarium against TB and MDR-TB
$282,999Lucila Garcia-Contreras · Oklahoma State University Stillwater · P20 · FY2020 · GM
CLASS II MHC TRANSPORT AND FUNCTION
$282,961Case Western Reserve University · R01 · FY2001 · AI
Altered M. tuberculosis Mannosylation and the Macrophage
$282,878Ohio State University · R21 · FY2002 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENTS
$282,821Chrisie Chesler · Utah State Department Of Health · U52 · FY2011 · PS
HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.
$282,804Yukari C Manabe · Johns Hopkins University · D43 · FY2016 · TW
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENTS
$282,776Chrisie Chesler · Utah State Department Of Health · U52 · FY2012 · PS
Direct activation of TGFbeta by an Mtb virulence factor to suppress CD4 T-cell responses
$282,750Christoph Grundner · Seattle Children'S Hospital · R21 · FY2021 · AI
Core C: Proteomics Core
$282,724Nevan J Krogan · University Of California Berkeley · P01 · FY2019 · AI
Role of Regulatory T cells in Leishmania major infection
$282,558Christopher L Karp · Cincinnati Childrens Hosp Med Ctr · R01 · FY2007 · AI
Mechanisms of Biological Fluoride Resistance Exporters
$282,548Christopher Miller · Brandeis University · R01 · FY2015 · GM
cAMP signaling in Mycobacterium tuberculosis
$282,537Kathleen A. McDonough · Wadsworth Center · R01 · FY2009 · AI
Targeted next-generation sequencing to enhance detection and genomic characterization of Mycobacterium tuberculosis and high-impact bacterial pathogens among HIV-infected adults with sepsis in Uganda
$282,467Max O'Donnell · Columbia University Health Sciences · R21 · FY2021 · AI
The Role of Cell Wall Lipids in Pathogenesis of Rifampin-Resistant TB
$282,430Petros C Karakousis · Johns Hopkins University · R01 · FY2015 · AI
Host genetic diversity, mononuclear phagocytes, and outcomes of TB
$282,333Joel D. Ernst · University Of California, San Francisco · R21 · FY2020 · AI
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target
$282,246Kevin A Reynolds · Portland State University · R01 · FY2006 · AI